Small, but significant effects seen at six months and sustained at 12 months
No increase observed in diagnoses following onset of COVID-19, but increase seen in proportion of women filling benzodiazepine prescription
Patients with CRS have increased risk for developing common psychiatric disorders and vice versa
Engagement and quality ratings were similar across incentive conditions
Single 20-minute session had significant efficacy for reducing pain intensity, pain unpleasantness, anxiety
Associations seen for chronic and new-onset anxiety, but not for resolved anxiety, with all-cause dementia risk
Single screening with the Multidimensional Health Assessment Questionnaire can be used in clinical practice